Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Migravas P 40mg/10mg Tablet

Prescription Icon
Prescription Required

Marketer

A N Pharmacia

Salt Composition

Propranolol (40mg) + Flunarizine (10mg)

Overview Migravas P 40mg/10mg Tablet

Migravas P 40mg/10mg tablets combine two medications for migraine prevention. This medication is unsuitable for treating acute migraine episodes. For optimal absorption, take Migravas P 40mg/10mg on an empty stomach, consistently at the same time each day, ideally before bed. Dosage and frequency depend on your individual needs, determined by your physician to manage your symptoms effectively. Continue this medication as directed by your doctor. Lifestyle changes, including stress reduction, smoking cessation, and limiting processed foods, can enhance its efficacy. Potential side effects include weight increase, bradycardia, fatigue, depression, somnolence, and cold extremities. Drowsiness is possible; avoid driving or tasks requiring alertness, and rise slowly from a seated position. This medication can mask hypoglycemia; regular blood glucose and blood pressure monitoring are essential. Inform your doctor of any pre-existing liver or kidney disease, depression, pregnancy, or breastfeeding before commencing treatment. Disclose all other medications you are using, as interactions may reduce Migravas P's effectiveness or alter its action.

Uses of Migravas P 40mg/10mg Tablet

Migraine Prevention Strategies

Major Benefits of Migravas P 40mg/10mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Migravas P 40mg/10mg tablets on an empty stomach.

Common Side effects of Migravas P 40mg/10mg Tablet:

  • Weight gain
  • Slow heart rate
  • Tiredness
  • Depression
  • Drowsiness
  • Abnormal dreams
  • Cold extremities

How to use Migravas P 40mg/10mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Migravas P 40mg/10mg Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Migravas P 40mg/10mg Tablet works:

Migravas P 40mg/10mg tablets combine propranolol, a beta-blocker, and flunarizine, a calcium channel blocker, to prevent migraine headaches. This dual action stabilizes hyperexcitable neurons, raising the threshold for migraine onset. Additionally, the medication suppresses cortical spreading depression, the electrical brainwave activity associated with migraine pain and inflammation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Migravas P 40mg/10mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Migravas P 40mg/10mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Migravas P 40mg/10mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving may be impaired by side effects of Migravas P 40mg/10mg Tablets. These potential side effects include visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, and drowsiness, all of which can negatively impact driving skills.

KidneyKidneySAFE IF PRESCRIBED

The use of Migravas P 40mg/10mg tablets in individuals with kidney disease appears to present a low risk. Preliminary evidence indicates that altering the dosage may be unnecessary, however, physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Migravas P 40mg/10mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Routine blood pressure checks are advised to guide dosage adjustments.

What if you forget to take Migravas P 40mg/10mg Tablet :

Should you forget a Migravas P 40mg/10mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Migravas P 40mg/10mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication HEART

FAQs on Migravas P 40mg/10mg Tablet

Migravas P 40mg/10mg Tablet is contraindicated in individuals hypersensitive to any component. The presence of propranolol necessitates caution in patients with asthma, bradycardia, cardiac arrhythmias, atrioventricular block, or sick sinus syndrome. Furthermore, the flunarizine component warrants avoidance in patients with a history of depression or Parkinson's disease.
Store Migravas P 40mg/10mg Tablets in their original, tightly sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Migravas P 40mg/10mg tablets serve as a preventative measure against migraine attacks. Discontinue use only under your physician's guidance, as cessation may trigger a recurrence of migraines. The medication includes propranolol; abrupt discontinuation can result in sweating, tremors, palpitations, aggravated angina, or myocardial infarction. Adhere strictly to your doctor's prescribed dosage of Migravas P 40mg/10mg tablets.
Migravas P 40mg/10mg tablets are ineffective for treating an ongoing migraine. Their purpose is solely the prevention of future migraine occurrences.
Migravas P 40mg/10mg Tabl...
99
MRP 121
18% off